Peripheral Drug Delivery Devices: Where Do We Stand?
Surveying the landscape of paclitaxel and sirolimus/everolimus devices for peripheral artery disease revascularization, with commentary on advantages and disadvantages and when each might be used, treatment algorithms for above the knee, the next wave of below-the-knee trial data, and the role of bioresorbables.
With Brian DeRubertis, MD; Andrew Holden, MD; Peter A. Schneider, MD; Sabine Steiner, MD; and Edward T.C. Choke, MBBS, FRCS, PhD
